La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Jean-Louis Montastruc18
Chimiothérapie293
Jean-Louis Montastruc Sauf Chimiothérapie" 10
Chimiothérapie Sauf Jean-Louis Montastruc" 285
Jean-Louis Montastruc Et Chimiothérapie 8
Jean-Louis Montastruc Ou Chimiothérapie 303
Corpus2807
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000937 Jean-Louis Montastruc [France] ; Agnès Sommet [France] ; Pascale Olivier [France] ; Haieh Bagheri [France] ; Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Christine Brefel-Courbon [France] ; Joachim Ferreira [Portugal] ; Laurent Schmitt [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France]Médicaments, maladie de Parkinson et syndromes parkinsoniens : actualités de pharmacovigilance
000D45 Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France]Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: A pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs
000D70 Olivier Rascol [France] ; Pierre Payoux [France, Portugal] ; Fabienne Ory [France] ; Joaquim J. Ferreira [France] ; Christine Brefel-Courbon [France] ; Jean-Louis Montastruc [France]Limitations of current Parkinson's disease therapy. Discussion
001030 Jean-Louis Montastruc [France] ; Christine Brefel-Courbon [France] ; Jean-Michel Senard [France] ; Haleh Bagheri [France] ; Joaquim Ferreira [France] ; Olivier Rascol [France] ; Maryse Lapeyre-Mestre [France]Sleep attacks and antiparkinsonian drugs : A pilot prospective pharmacoepidemiologic study
001039 Jean-Michel Senard [France] ; Christine Brefel-Courbon [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Orthostatic hypotension in patients with Parkinson's disease : Pathophysiology and management
001048 Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
001079 Olivier Rascol [France] ; Joaquim J. Ferreira [Portugal] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Jean-Louis Montastruc [France]Dopamine agonists: Their role in the management of Parkinson's disease
001246 Jean-Louis Montastruc [France] ; Cathy Chaumerliac [France] ; Karine Desboeuf [France] ; Mimosa Manika [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Maryse Lapeyre-Mestre [France]Adverse drug reactions to selegiline : A review of the French Pharmacovigilance Database

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024